China's COVID Dilemma

Dan discusses the economic toll of China's Zero COVID policy in 2022, highlighting the challenges faced due to ongoing lockdowns and reduced consumption. He explores the potential paths out, emphasizing the need for confidence in therapeutics and vaccines before any substantial easing of restrictions.